Surgical Sutures Market is predicted to grow at a 6.23% CAGR from the duration of 2021-2030

A surgical suture is regarded as a piece of medical equipment used to hold the bodily tissues together and roughly define the boundaries of wounds following an operation or injury. Typically, application entails the use of a needle with the help of a threaded attachment. Sterile surgical threads are widely used to close wounds & are often called sutures or stitches. They are frequently used to seal surgical incisions as well. Sutures may not always be necessary for some wounds; instead, metal staples may be needed.

The Surgical Sutures Market’s worth was $ 4.05 billion in 2021 & will value at $ 6.97 billion by 2030, with a 6.23% CAGR.

Non-absorbable sutures have a high demand in the market at present. It has a low coefficient of friction, goes through tissue with ease, & has little tissue reactivity, and has exceptional knot security. Irritation from the suture material’s clipped ends is the main drawback of the suture material tissue. Sutures offer stronger tensile strength and pose less of a threat to the skin’s blood supply. Additionally, the complete length of sutures wouldn’t have to be removed in the event of an infection. Running sutures are one of the greatest options for minimizing stress in long wounds or for controlling bleeding quickly.

Surgical Sutures prospects in future, trends, & its related statistics.

• A steep growth in cosmetic and aesthetic procedures has been observed in recent years, which can be attributed to a plethora of factors, including an aging population, rising disposable money, the availability of new technology, and growing procedural safety. For market participants in surgical sutures, the popularity of these therapies on a global scale opens up a significant potential opportunity. The ASPS/ American Society of Plastic Surgeons estimates that 17.9 million surgical and minimally invasive procedures were carried out in 2017 in the United States, representing a 1% rise in cosmetic surgeries between 2016 and 2017. Similar trends were observed in Europe, with increases of 134% in Italy, 0.5% in France, and almost 9% in Deutschland.
• The market is being significantly driven by an increase in cosmetic procedures as well as technology developments such as fractional lasers & cryolipolysis. 2019 had a 7.4% increase in cosmetic surgery procedures compared to 2018.
• In order to provide their citizens with access to proper healthcare facilities, several governments in emerging economies are attempting to ensure that an adequate supply of health insurance is available to more people in their respective countries. These elements raise the likelihood that the suture market will expand globally in such economies.

Segments included in this report:-

Product Type

• Automated Suturing Devices

• • Reusable Automated
  • Disposable Automated 

• Sutures 

• • Absorbable Sutures

• • • Synthetic Sutures

• • • • Monocryl Suture
      • Vicryl Sutures
      • Polyglycolic Sutures
      • Polydioxanone Sutures
      • Others
    • Natural Sutures

• • Non-absorbable Sutures

• • • Prolene Sutures
    • Nylon Sutures
    • Stainless Steel Sutures
    • Other

Application

• General Surgeries
• Cardiovascular Surgeries
• Orthopedic Surgeries
• Gynecological Surgeries
• Ophthalmic Surgeries
• Others

End-User

• ASCs
• Hospitals
• Clinics 

Players involved:

• Boston Scientific Corp
• B. Braun Melsungen AG
• Ethicon Inc. 
• Medtronic plc
• Smith & Nephew
• Teleflex Incorporated
• InternacionalFarmacéutica S.A. De C.V
• CONMED Corp
• Peters Surgical
• DemeTech Corp,
• EndoEvolution, LLC
• Sutures India
• Mellon Medical B.V.
• Surgical Specialties Corp

Recent Development

• On Aug 2022, a group of Swedish researchers created an artificial cornea from pig collagen that can restore the vision of eyes for blind individuals. In order to use this cornea on blind people, the scientists declared that they are creating some really cutting-edge eye suture technologies. However, because it is a foreign tissue to Homo sapiens, patients must return to the clinic for immune-suppressive eye drops on a regular basis for a year following surgery to adjust and remove the surgical sutures.
• On 2021. A non-absorbable PTFE suture was introduced by Dolphin Sutures, a world authority on surgical sutures. PTFE is a strong substance that knots quite easily and is inert to living things. Moreover, the removal of the suture is necessary within a stipulated time period; otherwise, it can lead to serious consequences.